Skip to main content
TCRX logo

TCRX · TScan Therapeutics, Inc.

$0.77 +0.00 (+0.23%) At close · Jul 28
Market Cap
$50.58M
Shares
65.35M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 61
Total Value: $33,028,250
Total Shares: 32,709,548

Institutional Ownership Trend

20 quarters

Holder Concentration

Across 60 13F filers
Top Holder
24.7%
Jun 2023 → Mar 2026 · range 12.5% – 26.1%
of institutional value
Top 5
62.6%
Jun 2023 → Mar 2026 · range 52.5% – 71.5%
of institutional value
Top 10
81.7%
Jun 2023 → Mar 2026 · range 75.2% – 93.8%
of institutional value
HHI
1,146
Jun 2023 → Mar 2026 · range 734 – 1,242
Broadly held
Showing 61 of 61
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1783328 CUSIP 89854M101 13F (30d) 4 filings 4 filers Visit website Investor relations